Cargando…

Current progress in pneumonia research

Detalles Bibliográficos
Autores principales:	Smelaya, T, Moroz, V, Goloubev, A, Salnikova, L, Rubanovich, A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934263/ http://dx.doi.org/10.1186/cc8308

Ejemplares similares

Host genetic variants associated with community-acquired pneumonia
por: Salnikova, LE, et al.
Publicado: (2013)

Inhaled tobramycin for the treatment of nosocomial pneumonia in sepsis
por: Kuzovlev, A, et al.
Publicado: (2014)

On the diagnosis of acute respiratory distress syndrome in nosocomial pneumonias
por: Kuzovlev, A, et al.
Publicado: (2010)

Complex approach for diagnosing acute respiratory distress syndrome in nosocomial pneumonia
por: Kuzovlev, A, et al.
Publicado: (2015)

Surfactant protein A: a candidate predictive biomarker of mortality in acute respiratory distress syndrome in sepsis
por: Moroz, V, et al.
Publicado: (2014)

Biomarkers for early stage of acute respiratory distress syndrome in septic patients: surfactant protein D and Clara cell protein
por: Kuzovlev, A, et al.
Publicado: (2013)

Genetic dissection of host immune response in pneumonia development and progression
por: Smelaya, Tamara V., et al.
Publicado: (2016)

Early preventive administration of inhaled tobramycin in severe polytrauma
por: Kuzovlev, A, et al.
Publicado: (2015)

Club Cell protein: a candidate diagnostic biomarker of Pseudomonas aeruginosa nosocomial pneumonia
por: Moroz, V, et al.
Publicado: (2014)

The current pathogens and treatment of hospital-acquired pneumonia/ventilator-associated pneumonia in medical intensive care units
por: Chang, Y, et al.
Publicado: (2015)

Physicians' perceptions of current management strategies for Gram-negative pneumonia: a multinational study
por: Frank, A
Publicado: (2009)

Using systematic reviews to identify research gaps - a case study: mIBG for the treatment of neuroblastoma in children
por: Wilson, Jayne, et al.
Publicado: (2013)

Pneumonia and Related Conditions in Critically Ill Patients—Insights from Basic and Experimental Studies
por: Kashatnikova, Darya A., et al.
Publicado: (2022)

Total antioxidant status and lipid metabolism in patients with severe multiple trauma
por: Muravyeva, M, et al.
Publicado: (2008)

Quantitative ultrasonography for pneumonia
por: Corradi, F, et al.
Publicado: (2015)

Association Study of Xenobiotic Detoxication and Repair Genes with Malignant Brain Tumors in Children
por: Salnikova, L.E., et al.
Publicado: (2010)

Efficacy of inhaled tobramycin in severe nosocomial pneumonia
por: Kuzovlev, A, et al.
Publicado: (2012)

Tyrosine metabolism disorder and the potential capability of anaerobic microbiota to decrease the value of aromatic metabolites in critically ill patients
por: Beloborodova, N, et al.
Publicado: (2014)

Fibrinolysis in early recognition of sepsis in patients with severe trauma
por: Gerasimov, Lev, et al.
Publicado: (2007)

Value of microbial metabolites in blood serum as criteria for bacterial load in the pathogenesis of hemodynamic disorders in critically ill patients
por: Sarshor, Y, et al.
Publicado: (2014)

Validation of predictive rules for ICU patients with community-acquired pneumonia
por: Rudnov, V, et al.
Publicado: (2008)

Flexible trial design in a rare condition
por: Moroz, Veronica, et al.
Publicado: (2013)

A comparison of acute lung inflammation in Klebsiella pneumoniae B5055-induced pneumonia and sepsis in BALB/c mice
por: Kumar, V, et al.
Publicado: (2009)

Ventilator-associated pneumonia in neuromuscular, tracheostomyzed patients
por: Martini, A, et al.
Publicado: (2005)

Nosocomial pneumonia and the main victim: the older person – measures for ventilator-associated pneumonia control
por: Guimarães, MMQ, et al.
Publicado: (2009)

Pneumococcal pneumonia coinfection in critically ill patients with influenza a (h1n1) primary viral pneumonia
por: González De Molina, FJ, et al.
Publicado: (2015)

Microbiology and outcomes of severe pneumonia in critically ill cancer patients
por: Rabello, L, et al.
Publicado: (2014)

Community-acquired pneumonia treated on the ICU
por: Apostolidou, E, et al.
Publicado: (2006)

Prognostic assessment in community-acquired pneumonia by pneumonia severity scores and biomarkers
por: Dusemund, F, et al.
Publicado: (2010)

Middle molecules in severe community-acquired pneumonia
por: Dumitras, T, et al.
Publicado: (2015)

Administration of meropenem for the treatment of ventilator-associated pneumonia
por: Zolotukhin, K, et al.
Publicado: (2007)

Effects of body orientation on the development of ventilator-associated pneumonia in mechanically ventilated swine
por: Cressoni, M, et al.
Publicado: (2009)

Outcome of patients with initial non-mechanical ventilation management in severe pneumonia
por: Ortín, A, et al.
Publicado: (2015)

Epidemiology of ventilator-associated pneumonia in ICU patients
por: Vakalos, A, et al.
Publicado: (2009)

Ventilator-associated pneumonia in a trauma ICU
por: Raja, M, et al.
Publicado: (2015)

Pneumonia in trauma patients
por: Giamberardino, HIG, et al.
Publicado: (2015)

Quality improvement: reducing ventilator-associated pneumonia
por: Hawe, C, et al.
Publicado: (2008)

Severe pneumonia in critically ill cancer patients: clinical outcomes and a comparison between healthcare-associated pneumonia and community-acquired pneumonia
por: Rabello, Ligia SCF, et al.
Publicado: (2013)

Comparison of the evolution of mechanical ventilation associated pneumonia (VAP) before the implantation of selective digestive decontamination (DDS) and after implantation of pneumonia zero program (NZ)
por: Fernández Fernández, R, et al.
Publicado: (2015)

Effect of age on resolution of ventilator-associated pneumonia
por: Sartzi, M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_8r1jtrsihmkfcpp0psdk052eu4